Holen Sie sich die Stockscreener-App
1.51
2.58%
-0.04
Handel nachbörslich:
1.47
-0.04
-2.65%
Schlusskurs vom Vortag:
$1.55
Offen:
$1.51
24-Stunden-Volumen:
160.82K
Relative Volume:
0.12
Marktkapitalisierung:
$4.69M
Einnahmen:
$32.96M
Nettoeinkommen (Verlust:
$-4.23M
KGV:
-0.00972
EPS:
-155.3294
Netto-Cashflow:
$-14.00M
1W Leistung:
+20.80%
1M Leistung:
-29.11%
6M Leistung:
-50.00%
1J Leistung:
-90.65%
1-Tages-Spanne:
$1.45
$1.57
1-Wochen-Bereich:
$1.21
$1.60
52-Wochen-Spanne:
$1.1693
$23.80
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Firmenname
Sunshine Biopharma Inc
Sektor
Telefon
954-515-0810
Adresse
333 LAS OLAS WAY, FORT LAUDERDALE
Vergleichen Sie SBFM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.51 | 4.69M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
153.47 | 65.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 46.99B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.18 | 45.96B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.87 | 17.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
291.38 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Sunshine Biopharma Inc Aktie (SBFM) Neueste Nachrichten
There is no doubt that Sunshine Biopharma Inc (SBFM) ticks all the boxes. - Sete News
Sunshine Becomes Latest To Compete On Everolimus In Canada - insights.citeline.com
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug - NewsBreak: Local News & Alerts
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug By Stocktwits - Investing.com India
SBFM Stock: A Comprehensive Analysis and Forecast - investchronicle.com
Press Release Distribution & PR Platform - ACCESS Newswire
SBFM’s valuation metrics: A comprehensive analysis - uspostnews.com
Sunshine Biopharma (SBFM) Finalizes $2.46 Million Stock Offering - GuruFocus
Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market - marketscreener.com
Sunshine Biopharma enters Canadian generic drug market with Everolimus - Investing.com
Sunshine Biopharma (SBFM) Launches Generic Everolimus in Canada | SBFM Stock News - GuruFocus
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion | SBFM Stock News - GuruFocus
Major Cancer Treatment Everolimus Enters Canadian Market: Multiple Cancer Types Targeted in $2.5B Opportunity - Stock Titan
Sunshine Biopharma stock hits 52-week low at $1.24 - Investing.com Australia
Sunshine Biopharma stock hits 52-week low at $1.24 By Investing.com - Investing.com India
Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 10.9% – Here’s Why - Defense World
Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline By Investing.com - Investing.com South Africa
Sunshine Biopharma Secures $2.46 Million in Direct Offering - TipRanks
Sunshine Biopharma Closes $2.5 Million Direct Offering - MarketScreener
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - ACCESS Newswire
SEC Form 424B5 filed by Sunshine Biopharma Inc. - Quantisnow
Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline - Investing.com India
Sunshine Biopharma’s K1.1-mRNA-LNP shows promise in HCC mouse model - BioWorld MedTech
The time has not yet come to remove your chips from the table: Sunshine Biopharma Inc (SBFM) - Sete News
Sunshine Biopharma secures $2.46 million in stock offering By Investing.com - Investing.com Canada
Sunshine Biopharma Reports 78% Revenue Growth and Key Developments in 2022 - TipRanks
Sunshine Biopharma (SBFM) Reports Increased Revenue Despite Net Loss - GuruFocus
Sunshine Biopharma (SBFM) Secures $2.46 Million in Direct Stock Offering - GuruFocus
Sunshine Biopharma secures $2.46 million in stock offering - Investing.com
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - ACCESS Newswire
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga
Biotech Stock Sunshine Biopharma Inc. (NASDAQ:SBFM) Makes NASDAQ Top Gainer List on News - Investorideas.com
This Pharma Stock Is Gaining Major Steam Ahead Of Opening Bell - The Globe and Mail
From Underdog to Top Performer: Sunshine Biopharma’s Impressive Surge - timothysykes.com
Sunshine Biopharma (SBFM) Announces Promising Results for Liver Cancer Treatment - GuruFocus
Sunshine Biopharma reports progress in liver cancer treatment - Investing.com India
Sunshine Biopharma Completes Additional Studies of mRNA Therapy for Liver Cancer; Shares Up Pre-Bell - MarketScreener
Pre-market Movers: IBG, JYD, SBFM, SPWH, RSLS… - RTTNews
Revolutionary mRNA Treatment Succeeds Against Deadly Liver Cancer in Latest Trial - Stock Titan
Sunshine Biopharma (SBFM) Reports 2024 Financial Highlights - GuruFocus
Sunshine Biopharma Reports Record Revenue: 13 New Drugs and Cancer Treatment Breakthrough - Stock Titan
Sunshine Biopharma Inc. SEC 10-K Report - TradingView
Sunshine Biopharma Inc expected to post earnings of 11 cents a shareEarnings Preview - TradingView
Sunshine Biopharma signs agreement for rights to market two generic antibiotics - Yahoo Finance
Sunshine Biopharma to market new antibiotics in Canada By Investing.com - Investing.com Australia
Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada - MSN
Sunshine Biopharma to market new antibiotics in Canada - Investing.com India
Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
1.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):